Sernova Corp. PSH.DE Stock
Sernova Corp. Price Chart
Sernova Corp. PSH.DE Financial and Trading Overview
| Sernova Corp. stock price | 0.33 EUR |
| Previous Close | 0.61 EUR |
| Open | 0.58 EUR |
| Bid | 0.56 EUR x N/A |
| Ask | 0.63 EUR x N/A |
| Day's Range | 0.58 - 0.58 EUR |
| 52 Week Range | 0.49 - 1.07 EUR |
| Volume | 177 EUR |
| Avg. Volume | 3.67K EUR |
| Market Cap | 250.93M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PSH.DE Valuation Measures
| Enterprise Value | 151.76M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.471698 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.679 |
Trading Information
Sernova Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -32.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.07 EUR |
| 52 Week Low | 0.49 EUR |
| 50-Day Moving Average | 0.6 EUR |
| 200-Day Moving Average | 0.65 EUR |
PSH.DE Share Statistics
| Avg. Volume (3 month) | 3.67K EUR |
| Avg. Daily Volume (10-Days) | 5.07K EUR |
| Shares Outstanding | 303.33M |
| Float | 260.63M |
| Short Ratio | N/A |
| % Held by Insiders | 14.46% |
| % Held by Institutions | 0.049% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -63.27% |
| Return on Equity (ttm) | -112.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -32432032 EUR |
| Net Income Avi to Common (ttm) | -31404072 EUR |
| Diluted EPS (ttm) | -0.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.6M EUR |
| Total Cash Per Share (mrq) | 0.12 EUR |
| Total Debt (mrq) | 208.93K EUR |
| Total Debt/Equity (mrq) | 0.65 EUR |
| Current Ratio (mrq) | 6.282 |
| Book Value Per Share (mrq) | 0.106 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24050764 EUR |
| Levered Free Cash Flow (ttm) | -14584641 EUR |
Profile of Sernova Corp.
| Country | Germany |
| State | ON |
| City | London |
| Address | The Stiller Centre |
| ZIP | N6G 4X8 |
| Phone | N/A |
| Website | https://www.sernova.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells;a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform; and research collaboration with AstraZeneca PLC to evaluate novel potential therapeutic cell applications. The company was incorporated in 1998 and is headquartered in London, Canada.
Q&A For Sernova Corp. Stock
What is a current PSH.DE stock price?
Sernova Corp. PSH.DE stock price today per share is 0.33 EUR.
How to purchase Sernova Corp. stock?
You can buy PSH.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sernova Corp.?
The stock symbol or ticker of Sernova Corp. is PSH.DE.
Which industry does the Sernova Corp. company belong to?
The Sernova Corp. industry is Biotechnology.
How many shares does Sernova Corp. have in circulation?
The max supply of Sernova Corp. shares is 427.53M.
What is Sernova Corp. Price to Earnings Ratio (PE Ratio)?
Sernova Corp. PE Ratio is now.
What was Sernova Corp. earnings per share over the trailing 12 months (TTM)?
Sernova Corp. EPS is -0.13 EUR over the trailing 12 months.
Which sector does the Sernova Corp. company belong to?
The Sernova Corp. sector is Healthcare.